PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO.JK)
IDR 540.0
(-3.57%)
IDR 540.0
(-3.57%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -820.73 Billion IDR | 10.85% |
| 2022 | -920.66 Billion IDR | 14.24% |
| 2021 | -1073.54 Billion IDR | -4.76% |
| 2020 | -1024.76 Billion IDR | -18.49% |
| 2019 | -864.82 Billion IDR | -7.32% |
| 2018 | -805.83 Billion IDR | 10.75% |
| 2017 | -902.85 Billion IDR | 9.46% |
| 2016 | -997.13 Billion IDR | -19.14% |
| 2015 | -836.97 Billion IDR | 3.22% |
| 2014 | -864.79 Billion IDR | 35.89% |
| 2013 | -1348.95 Billion IDR | -1106.03% |
| 2012 | -111.85 Billion IDR | -183.41% |
| 2011 | 134.1 Billion IDR | 428.02% |
| 2010 | -40.88 Billion IDR | -142.23% |
| 2009 | 96.8 Billion IDR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -714.88 Billion IDR | 34.59% |
| 2024 Q1 | -1092.92 Billion IDR | -33.16% |
| 2024 Q3 | -974.93 Billion IDR | -36.38% |
| 2023 Q2 | -443.41 Billion IDR | 59.79% |
| 2023 Q1 | -1102.6 Billion IDR | -19.76% |
| 2023 FY | -820.73 Billion IDR | 10.85% |
| 2023 Q4 | -820.73 Billion IDR | -6.07% |
| 2023 Q3 | -773.79 Billion IDR | -74.51% |
| 2022 FY | -920.66 Billion IDR | 14.24% |
| 2022 Q4 | -920.66 Billion IDR | -7.99% |
| 2022 Q1 | -1248.41 Billion IDR | -16.29% |
| 2022 Q3 | -852.58 Billion IDR | -43.54% |
| 2022 Q2 | -593.95 Billion IDR | 52.42% |
| 2021 Q2 | -790.58 Billion IDR | 36.58% |
| 2021 Q1 | -1246.6 Billion IDR | -21.65% |
| 2021 FY | -1073.54 Billion IDR | -4.76% |
| 2021 Q4 | -1073.54 Billion IDR | -31.18% |
| 2021 Q3 | -818.39 Billion IDR | -3.52% |
| 2020 Q3 | -1027.49 Billion IDR | -31.24% |
| 2020 Q1 | -1045.11 Billion IDR | -20.85% |
| 2020 Q4 | -1024.76 Billion IDR | 0.27% |
| 2020 FY | -1024.76 Billion IDR | -18.49% |
| 2020 Q2 | -782.89 Billion IDR | 25.09% |
| 2019 Q1 | -912.25 Billion IDR | -13.21% |
| 2019 FY | -864.82 Billion IDR | -7.32% |
| 2019 Q3 | -959.45 Billion IDR | -26.48% |
| 2019 Q2 | -758.55 Billion IDR | 16.85% |
| 2019 Q4 | -864.82 Billion IDR | 9.86% |
| 2018 FY | -805.83 Billion IDR | 10.75% |
| 2018 Q4 | -805.83 Billion IDR | 7.75% |
| 2018 Q3 | -873.51 Billion IDR | 17.51% |
| 2018 Q2 | -1058.9 Billion IDR | -11.89% |
| 2018 Q1 | -946.36 Billion IDR | -4.82% |
| 2017 Q1 | -964.31 Billion IDR | 3.29% |
| 2017 Q2 | -714.6 Billion IDR | 25.89% |
| 2017 Q3 | -810.36 Billion IDR | -13.4% |
| 2017 Q4 | -902.85 Billion IDR | -11.41% |
| 2017 FY | -902.85 Billion IDR | 9.46% |
| 2016 Q3 | -820.9 Billion IDR | -10.8% |
| 2016 FY | -997.13 Billion IDR | -19.14% |
| 2016 Q4 | -997.13 Billion IDR | -21.47% |
| 2016 Q2 | -740.9 Billion IDR | 8.91% |
| 2016 Q1 | -813.4 Billion IDR | 2.82% |
| 2015 Q1 | -902.62 Billion IDR | -4.37% |
| 2015 FY | -836.97 Billion IDR | 3.22% |
| 2015 Q4 | -836.97 Billion IDR | 2.34% |
| 2015 Q3 | -857.05 Billion IDR | -2.95% |
| 2015 Q2 | -832.51 Billion IDR | 7.77% |
| 2014 Q4 | -864.79 Billion IDR | -9.17% |
| 2014 Q3 | -792.15 Billion IDR | -14.39% |
| 2014 Q2 | -692.47 Billion IDR | 49.39% |
| 2014 Q1 | -1368.26 Billion IDR | -1.43% |
| 2014 FY | -864.79 Billion IDR | 35.89% |
| 2013 Q2 | 86.21 Billion IDR | -79.01% |
| 2013 Q1 | 410.73 Billion IDR | 0.0% |
| 2013 FY | -1348.95 Billion IDR | -1106.03% |
| 2013 Q4 | -1348.95 Billion IDR | 0.0% |
| 2012 FY | -111.85 Billion IDR | -183.41% |
| 2011 FY | 134.1 Billion IDR | 428.02% |
| 2010 FY | -40.88 Billion IDR | -142.23% |
| 2009 FY | 96.8 Billion IDR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | -238.56 Billion IDR | -244.025% |
| PT Merck Tbk | -183.3 Billion IDR | -347.746% |
| PT Phapros, Tbk | 736.73 Billion IDR | 211.401% |
| PT Pyridam Farma Tbk | 897.02 Billion IDR | 191.496% |
| PT Tempo Scan Pacific Tbk | -2577.85 Billion IDR | 68.162% |